Pregnancy and venous thromboembolism

Seminars in Thrombosis and Hemostasis

Volumn 39, Issue 5, 2013, Pages 549-558

  Barco, Stefano ^a,b   Nijkeuter, Mathilde ^a   Middeldorp, Saskia ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

anticoagulants; hemostasis; pregnancy; pulmonary embolism; venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; DEEP VEIN THROMBOSIS; DELIVERY; FAMILY HISTORY; FIBRINOLYSIS; HUMAN; MORTALITY; PATHOPHYSIOLOGY; POSTTHROMBOSIS SYNDROME; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; VENOUS THROMBOEMBOLISM;

FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PULMONARY EMBOLISM; RISK FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84879110047     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0033-1343893     Document Type: Article

References (84)

1. James A. H., Jamison M. G., Brancazio L. R., Myers E. R. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol: 2006; 194 5 1311 1315
2. Naess I. A., Christiansen S. C., Romundstad P., Cannegieter S. C., Rosendaal F. R., Hammerstrom J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost: 2007; 5 4 692 699
3. Chang J., Elam-Evans L. D., Berg C. J., et al. Pregnancy-related mortality surveillance-United States, 1991-1999. MMWR Surveill Summ: 2003; 52 2 1 8
4. Bourjeily G., Paidas M., Khalil H., Rosene-Montella K., Rodger M. Pulmonary embolism in pregnancy. Lancet: 2010; 375 9713 500 512
5. McColl M. D., Ramsay J. E., Tait R. C., et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost: 1997; 78 4 1183 1188
6. Heit J. A., Kobbervig C. E., James A. H., Petterson T. M., Bailey K. R., Melton L. J. III. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med: 2005; 143 10 697 706
7. Simpson E. L., Lawrenson R. A., Nightingale A. L., Farmer R. D. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG: 2001; 108 1 56 60
8. Gherman R. B., Goodwin T. M., Leung B., Byrne J. D., Hethumumi R., Montoro M. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol: 1999; 94 5 Pt 1 730 734
9. Ray J. G., Chan W. S. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv: 1999; 54 4 265 271
10. Virkus R. A., Lokkegaard E. CL, Bergholt T., Mogensen U., Langhoff-Roos J., Lidegaard O. Venous thromboembolism in pregnant and puerperal women in Denmark 1995-2005. A national cohort study. Thromb Haemost: 2011; 106 2 304 309
11. White R. H., Brickner L. A., Scannell K. A. ICD-9-CM codes poorly identified venous thromboembolism during pregnancy. J Clin Epidemiol: 2004; 57 9 985 988
12. Sultan A. A., West J., Tata L. J., Fleming K. M., Nelson-Piercy C., Grainge M. J. Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study. Br J Haematol: 2012; 156 3 366 373
13. Jacobsen A. F., Skjeldestad F. E., Sandset P. M. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost: 2008; 6 6 905 912
14. Danilenko-Dixon D. R., Heit J. A., Silverstein M. D., et al. Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. Am J Obstet Gynecol: 2001; 184 2 104 110
15. Bates S. M., Greer I. A., Middeldorp S., Veenstra D. L., Prabulos A-M, Vandvik P. O. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest: 2012; 141 2 Suppl e691S 736S
16. Lussana F., Coppens M., Cattaneo M., Middeldorp S. Pregnancy-related venous thromboembolism: risk and the effect of thromboprophylaxis. Thromb Res: 2012; 129 6 673 680
17. Robertson L., Wu O., Langhorne P., et al. Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study Thrombophilia in pregnancy: a systematic review. Br J Haematol: 2006; 132 2 171 196
18. Conard J., Horellou M. H., Van Dreden P., Lecompte T., Samama M. Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women. Thromb Haemost: 1990; 63 2 319 320
19. Bezemer I. D., van der Meer F. JM, Eikenboom J. CJ, Rosendaal F. R., Doggen C. JM. The value of family history as a risk indicator for venous thrombosis. Arch Intern Med: 2009; 169 6 610 615
20. Pabinger I., Grafenhofer H., Kyrle P. A., et al. Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood: 2002; 100 3 1060 1062
21. De Stefano V., Martinelli I., Rossi E., et al. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br J Haematol: 2006; 135 3 386 391
22. Bergrem A., Jacobsen E. M., Skjeldestad F. E., Jacobsen A. F., Skogstad M., Sandset P. M. The association of antiphospholipid antibodies with pregnancy-related first time venous thrombosis-a population-based case-control study. Thromb Res: 2010; 125 5 e222 e227
23. Macklon N. S., Greer I. A., Bowman A. W. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy. Br J Obstet Gynaecol: 1997; 104 2 191 197
24. Hodges Y. K., Richer J. K., Horwitz K. B., Horwitz L. D. Variant estrogen and progesterone receptor messages in human vascular smooth muscle. Circulation: 1999; 99 20 2688 2693
25. Brenner B. Haemostatic changes in pregnancy. Thromb Res: 2004; 114 5-6 409 414
26. Clark P., Brennand J., Conkie J. A., McCall F., Greer I. A., Walker I. D. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost: 1998; 79 6 1166 1170
27. Khalafallah A. A., Morse M., Al-Barzan A-M., et al. D-dimer levels at different stages of pregnancy in Australian women: a single centre study using two different immunoturbidimetric assays. Thromb Res: 2012; 130 3 e171 e177
28. Bretelle F., Sabatier F., Desprez D., et al. Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Thromb Haemost: 2003; 89 3 486 492
29. Chan W-S, Spencer F. A., Ginsberg J. S. Anatomic distribution of deep vein thrombosis in pregnancy. CMAJ: 2010; 182 7 657 660
30. Wells P. S., Anderson D. R., Bormanis J., et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet: 1997; 350 9094 1795 1798
31. Barrellier M. T., Lezin B., Monsallier J. M. [Isolated iliac deep venous thrombosis. Study of 48 cases seen in 7 years among 18,297 echo-Doppler evaluations of the lower limbs]. J Mal Vasc: 2001; 26 5 290 298
32. Leung A. N., Bull T. M., Jaeschke R., et al. ATS/STR Committee on Pulmonary Embolism in Pregnancy An official American Thoracic Society/Society of Thoracic Radiology clinical practice guideline: evaluation of suspected pulmonary embolism in pregnancy. Am J Respir Crit Care Med: 2011; 184 10 1200 1208
33. Shahir K., Goodman L. R., Tali A., Thorsen K. M., Hellman R. S. Pulmonary embolism in pregnancy: CT pulmonary angiography versus perfusion scanning. AJR Am J Roentgenol: 2010; 195 3 W214-20
34. Revel M-P, Cohen S., Sanchez O., et al. Pulmonary embolism during pregnancy: diagnosis with lung scintigraphy or CT angiography? Radiology: 2011; 258 2 590 598
35. Middeldorp S. How I treat pregnancy-related venous thromboembolism. Blood: 2011; 118 20 5394 5400
36. Nijkeuter M., Ginsberg J. S., Huisman M. V. Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy: a systematic review. J Thromb Haemost: 2006; 4 3 496 500
37. Chan W. S., Anand S., Ginsberg J. S. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med: 2000; 160 2 191 196
38. Wesseling J., Van Driel D., Smrkovsky M., et al. Neurological outcome in school-age children after in utero exposure to coumarins. Early Hum Dev: 2001; 63 2 83 95
39. Wesseling J., Van Driel D., Heymans H. S., et al. Coumarins during pregnancy: long-term effects on growth and development of school-age children. Thromb Haemost: 2001; 85 4 609 613
40. Greer I. A., Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood: 2005; 106 2 401 407
41. Lepercq J., Conard J., Borel-Derlon A., et al. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. BJOG: 2001; 108 11 1134 1140
42. Knight M.; UKOSS. Antenatal pulmonary embolism: risk factors, management and outcomes. BJOG: 2008; 115 4 453 461
43. Voke J., Keidan J., Pavord S., Spencer N. H., Hunt B. J.; British Society for Haematology Obstetric Haematology Group. The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey. Br J Haematol: 2007; 139 4 545 558
44. Chunilal S. D., Young E., Johnston M. A., et al. The APTT response of pregnant plasma to unfractionated heparin. Thromb Haemost: 2002; 87 1 92 97
45. Kovacs M. J., Keeney M. Inter-assay and instrument variability of anti-Xa-results. Thromb Haemost: 2000; 84 1 138
46. Casele H. L., Laifer S. A., Woelkers D. A., Venkataramanan R. Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy. Am J Obstet Gynecol: 1999; 181 5 Pt 1 1113 1117
47. Barbour L. A., Oja J. L., Schultz L. K. A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation. Am J Obstet Gynecol: 2004; 191 3 1024 1029
48. Jacobsen A. F., Qvigstad E., Sandset P. M. Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy. BJOG: 2003; 110 2 139 144
49. Greinacher A. Heparin-induced thrombocytopenia. J Thromb Haemost: 2009; 7 01 9 12
50. Linkins L-A, Dans A. L., Moores L. K., et al. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest: 2012; 141 2 Suppl): e495S 530S
51. Gerdsen F., Luxembourg B., Langer F., Bauersachs R., Lindhoff-Last E. A prospective analysis of heparin-platelet factor 4 antibodies in pregnant women treated with the low-molecular-weight heparin, dalteparin. Blood Coagul Fibrinolysis: 2008; 19 6 477 481
52. Nagler M., Haslauer M., Wuillemin W. A. Fondaparinux - data on efficacy and safety in special situations. Thromb Res: 2012; 129 4 407 417
53. Ciurzyński M., Jankowski K., Pietrzak B., et al. Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia. Med Sci Monit: 2011; 17 5 CS56 -CS59
54. Knol H. M., Schultinge L., Erwich J. JHM, Meijer K. Fondaparinux as an alternative anticoagulant therapy during pregnancy. J Thromb Haemost: 2010; 8 8 1876 1879
55. Dempfle C-EH. Minor transplacental passage of fondaparinux in vivo. N Engl J Med: 2004; 350 18 1914 1915
56. GlaxoSmithKline Inc. Product Monograph-Fondaparinux. Data of text revision: June 7, 2012. Available at: http://www.gsk.ca/english/docs-pdf/ product-monographs/Arixtra.pdf. Accessed April 10, 2013
57. Bayer Inc Product monograph-Rivaroxaban tablet. Date of text revision: July 18, 2012. Available at: http://www.bayer.ca/files/XARELTO-PM-ENG-18JUL2012- 154961.pdf. Accessed April 10, 2013
58. Boehringer Ingelheim Canada Ltd Product monograph-Dabigatran etexilate capsules. Date of text revision: January 27, 2012. Available at: http://www.boehringer-ingelheim.ca/content/dam/internet/opu/ca-EN/documents/ humanhealth/product-monograph/Pradax-pm.pdf. Accessed April 10, 2013
59. Tengborn L., Bergqvist D., Mätzsch T., Bergqvist A., Hedner U. Recurrent thromboembolism in pregnancy and puerperium. Is there a need for thromboprophylaxis? Am J Obstet Gynecol: 1989; 160 1 90 94
60. Pabinger I., Grafenhofer H., Kaider A., et al. Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. J Thromb Haemost: 2005; 3 5 949 954
61. Sanson B. J., Lensing A. W., Prins M. H., et al. Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost: 1999; 81 5 668 672
62. Brill-Edwards P., Ginsberg J. S., Gent M., et al. Recurrence of Clot in This Pregnancy Study Group Safety of withholding heparin in pregnant women with a history of venous thromboembolism. N Engl J Med: 2000; 343 20 1439 1444
63. Crowther M. A., Spitzer K., Julian J., et al. Pharmacokinetic profile of a low-molecular weight heparin (reviparin) in pregnant patients. A prospective cohort study. Thromb Res: 2000; 98 2 133 138
64. Kominiarek M. A., Angelopoulos S. M., Shapiro N. L., Studee L., Nutescu E. A., Hibbard J. U. Low-molecular-weight heparin in pregnancy: peripartum bleeding complications. J Perinatol: 2007; 27 6 329 334
65. Roshani S., Cohn D. M., Stehouwer A. C., et al. Incidence of postpartum haemorrhage in women receiving therapeutic doses of low-molecular-weight heparin: results of a retrospective cohort study. BMJ Open: 2011; 1 2 e000257
66. Ganguli S., Tham J. C., Komlos F., Rabkin D. J. Fracture and migration of a suprarenal inferior vena cava filter in a pregnant patient. J Vasc Interv Radiol: 2006; 17 10 1707 1711
67. Prandoni P., Kahn S. R. Post-thrombotic syndrome: prevalence, prognostication and need for progress. Br J Haematol: 2009; 145 3 286 295
68. Musani M. H., Matta F., Yaekoub A. Y., Liang J., Hull R. D., Stein P. D. Venous compression for prevention of postthrombotic syndrome: a meta-analysis. Am J Med: 2010; 123 8 735 740
69. Prandoni P., Noventa F., Quintavalla R., et al. Canano Investigators Thigh-length versus below-knee compression elastic stockings for prevention of the postthrombotic syndrome in patients with proximal-venous thrombosis: a randomized trial. Blood: 2012; 119 6 1561 1565
70. Wik H. S., Jacobsen A. F., Sandvik L., Sandset P. M. Prevalence and predictors for post-thrombotic syndrome 3 to 16 years after pregnancy-related venous thrombosis: a population-based, cross-sectional, case-control study. J Thromb Haemost: 2012; 10 5 840 847
71. Verberg M. FG, Gillott D. J., Al-Fardan N., Grudzinskas J. G. Hyperemesis gravidarum, a literature review. Hum Reprod Update: 2005; 11 5 527 539
72. Epiney M., Boehlen F., Boulvain M., et al. D-dimer levels during delivery and the postpartum. J Thromb Haemost: 2005; 3 2 268 271
73. Rees D. C., Cox M., Clegg J. B. World distribution of factor V Leiden. Lancet: 1995; 346 8983 1133 1134
74. Poort S. R., Rosendaal F. R., Reitsma P. H., Bertina R. M. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood: 1996; 88 10 3698 3703
75. Tait R. C., Walker I. D., Perry D. J., et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol: 1994; 87 1 106 112
76. Miletich J., Sherman L., Broze G. Jr. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med: 1987; 317 16 991 996
77. Dykes A. C., Walker I. D., McMahon A. D., Islam S. I., Tait R. C. A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol: 2001; 113 3 636 641
78. Middeldorp S., Henkens C. M., Koopman M. M., et al. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis. Ann Intern Med: 1998; 128 1 15 20
79. Simioni P., Sanson B. J., Prandoni P., et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost: 1999; 81 2 198 202
80. Middeldorp S., Libourel E. J., Hamulyák K., Van der Meer J., Büller H. R. The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden. Br J Haematol: 2001; 113 2 553 555
81. Martinelli I., Legnani C., Bucciarelli P., Grandone E., De Stefano V., Mannucci P. M. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost: 2001; 86 3 800 803
82. Bank I., Libourel E. J., Middeldorp S., et al. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study. Arch Intern Med: 2004; 164 17 1932 1937
83. Friederich P. W., Sanson B. J., Simioni P., et al. Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Ann Intern Med: 1996; 125 12 955 960
84. Martinelli I., Battaglioli T., De Stefano V., et al. GIT (Gruppo Italiano Trombofilia) The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A. J Thromb Haemost: 2008; 6 3 494 498